Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
  • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
  • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
  • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
  • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
  • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
  • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
  • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B82—NANOTECHNOLOGY
  • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
  • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Applications Claiming Priority (1)

Publications (2)

Family

ID=10994670

Family Applications (1)

Country Status (20)

Families Citing this family (7)

Family Cites Families (5)

• 1977
  • 1977-09-23 HU HU77CI1770A patent/HU179141B/hu not_active IP Right Cessation
• 1978
  • 1978-09-13 GR GR57216A patent/GR65001B/el unknown
  • 1978-09-13 IL IL55569A patent/IL55569A/xx unknown
  • 1978-09-15 DE DE19782840142 patent/DE2840142A1/de not_active Ceased
  • 1978-09-18 CS CS786036A patent/CS200242B2/cs unknown
  • 1978-09-19 IT IT69160/78A patent/IT1160661B/it active
  • 1978-09-19 YU YU02206/78A patent/YU220678A/xx unknown
  • 1978-09-20 AT AT0677478A patent/AT369362B/de not_active IP Right Cessation
  • 1978-09-21 FI FI782878A patent/FI65912C/fi not_active IP Right Cessation
  • 1978-09-21 DD DD78208003A patent/DD138600A5/xx unknown
  • 1978-09-21 FR FR7827079A patent/FR2404006A1/fr active Granted
  • 1978-09-21 SE SE7809946A patent/SE447574B/sv not_active IP Right Cessation
  • 1978-09-21 BE BE190613A patent/BE870646A/xx not_active IP Right Cessation
  • 1978-09-22 CH CH995078A patent/CH637388A5/de not_active IP Right Cessation
  • 1978-09-22 NL NL7809643A patent/NL7809643A/xx not_active Application Discontinuation
  • 1978-09-22 JP JP11738378A patent/JPS5456685A/ja active Pending
  • 1978-09-22 DK DK420778A patent/DK420778A/da not_active Application Discontinuation
  • 1978-09-22 PL PL1978209773A patent/PL121664B1/pl unknown
  • 1978-09-22 GB GB7837834A patent/GB2006193B/en not_active Expired
  • 1978-09-22 SU SU782668853A patent/SU847914A3/ru active

Also Published As

Similar Documents